<ѻý>FDA Gives Nod to Gene Therapy for Hemophilia Aѻý> First gene therapy approved for severe hemophilia A Jun 29, 2023
<ѻý>'Winners' and 'Losers'; Mandated Sick Leave and Cancer Screening; More AI Advancesѻý> News, features, and commentary about cancer-related issues Mar 03, 2023
<ѻý>Gene Tx Shows Sustained Bleeding Control in Severe Hemophilia A at 2 Yearsѻý> Model predicts valoctocogene roxaparvovec could maintain mild hemophilia levels for 5 years Feb 23, 2023
<ѻý>New Class of Factor VIII Replacement Therapy Prevents Bleeds in Severe Hemophilia Aѻý> Weekly dosing with efanesoctocog alfa reduced annualized bleeding rate by 77% Jan 25, 2023
<ѻý>FDA OKs First Gene Therapy for Hemophilia Bѻý> Hemgenix reduced rate of annual bleeds, eliminated need for factor IX prophylaxis therapy Nov 22, 2022
<ѻý>Year in Review: Hemophiliaѻý> Gene therapy continues to show promise in clinical trials, but is it ready for the clinic? Nov 17, 2022
<ѻý>'Unparalleled Times' in Hematology, but Workforce Issues Persistѻý> "This is the most exciting time ever" to be a hematologist, says ASH President Jane Winter, MD Sep 26, 2022 video
<ѻý>Lessons From a Lifelong Patient Turned Oncologistѻý> Eric Winer, MD, talks about how growing up with hemophilia helped him connect with patients Aug 02, 2022 podcast
<ѻý>Fitusiran Prophylaxis Cuts Bleeding in Hemophilia A/Bѻý> Monthly infusion vs on-demand bypassing agents effective in patients with or without inhibitors Dec 14, 2021
<ѻý>Liver Toxicity in Gene Therapy Trials Could Merit Stricter Entry Criteriaѻý> FDA panel weighs in on lower vector doses and role of animal studies Sep 03, 2021
<ѻý>Whole-Genome Sequencing Makes a Case in Leukemia Studyѻý> More actionable alterations detected in myeloid malignancies versus cytogenetics Mar 10, 2021
<ѻý>Gene Therapy Stops Bleeding in Hemophiliaѻý> Single injection had durable effectiveness, study showed Dec 08, 2020
<ѻý>Severe Nosebleeds More Common With Hypertensionѻý> Korean study supports link between hypertension and epistaxis Sep 10, 2020
<ѻý>MSK Cancer Alliance: Mainly About Medicineѻý> Bi-directional relationship strengthens regional cancer care Mar 11, 2017
<ѻý>Combo Boosts PFS in Tough-to-Treat Myelomaѻý> Recurrent or relapsed disease susceptible to daratumumab-bortezomib-dexamethasone Jun 07, 2016